account_id none on file
legal_name Genprex, Inc.
ticker GNPX
cik 1595248
domain genprex.com
linkedin_company_url http://linkedin.com/company/genprex
entry_point_account_id none on file
name Genprex Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 2 executives 3 family 0
why_nownone on file
callsnone on file
filings
The slight period-over-period decrease in 2026 from 2025 in G&A expenses was primarily due to adherence of expense reduction strategies implemented by leadership in the year ended December 31, 2024 and maintained through the six months ended June 30, 2026.
filing / Aug 14, 2026 / receipt
The difference in net loss between the respective periods was mostly flat primarily due to adherence of expense reduction strategies implemented by leadership in the year ended December 31, 2024 and maintained through the six months ended June 30, 2026.
filing / Aug 14, 2026 / receipt
executives
| Catherine M. Vaczy | Executive Vice President and Chief Strategy Officer | - | receipt |
| J. Rodney Varner | President | - | receipt |
| Ryan Confer | President and Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changes
| 2024-05-09 | President and Chief Executive Officer, appointed | sec_8k |
| 2020-08-14 | President, appointed | sec_8k |
| 2020-03-23 | Executive Vice President and Chief Strategy Officer, appointed | sec_8k |
mcp_package_hint
slug genprex-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$